Purchase Order W81K0221P0096
Award Date 7/1/21
Potential Completion Date 9/30/25
Potential Value $1.6M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46250, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price delivery order awarded to Roche Diagnostics Corporation by the Defense Health Agency, a component of the Department of Defense. The contract, valued at $228,012.48, is for the supply of chemistry immunoassay analyzers and associated reagents for the General Leonard Wood Army Community Hospital in Fort Leonard Wood, Missouri. The contract has an ultimate completion date of March 31, 2026 and is not set aside for any specific business category. Roche Diagnostics...
- The Department of the Army Medical Command awarded a $177,482.40 firm fixed price delivery order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of test reagents and has a completion date of September 30, 2022. Roche has previously received other federal contract awards, including Indefinite Delivery Contracts and Blanket Purchase Agreements, to supply a range of medical...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic equipment and reagents, has been awarded a delivery order valued at $722,715.31 by the Defense Health Agency for an Automated Core Lab. The order is firm fixed price with no set-aside designation and is scheduled for completion by September 30, 2025. The work will be performed in Castleton, Indiana, and represents a child contract—indicating it derives from a larger contract vehicle, likely one of Roche's...
- This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $262,962.36 contract is for the supply of reagents and consumables to support the government-owned Roche b221 blood gas analyzers at Madigan Army Medical Center, Joint Base Lewis-McChord in Washington. The contract has a period of performance through September 30, 2025. This...
- Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic products and laboratory instruments, was awarded a $4.48M firm fixed-price purchase order by the Defense Health Agency to supply clinical chemistry and immunoassay reagents and analyzers to Tripler Army Medical Center in Hawaii. This award represents the exercise of Option III under the contract, covering the period from October 1, 2025 through September 30, 2026, with an ultimate completion date of September...
- The Defense Health Agency awarded a delivery order to Roche Diagnostics Corporation on December 1, 2022, for the provision of clinical chemistry and immunoassay analyzers on a cost-per-test basis. This firm fixed-price contract, valued at approximately $3.62 million with a completion date of September 30, 2027, will be performed in Castleton, Indiana. The contract was issued without set-aside designation, allowing Roche Diagnostics to compete openly in the federal marketplace. This delivery...
- This federal contract award is for a chemistry analyzer from Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $9,280.72 firm fixed-price purchase order was awarded on October 1, 2021 by the Defense Health Agency, with an ultimate completion date of September 30, 2026. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and associated...
- The U.S. Defense Health Agency awarded a $1,691,672.05 firm-fixed-price definitive contract to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, for BRIDGE CHEMISTRY ANALYZER SERVICES and WAMC CHEMISTRY TESTING REAGENTS. The contract has an ultimate completion date of March 31, 2025. Roche Diagnostics is a global leader in diagnostic solutions and has multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs)...
- The Defense Health Agency awarded a $2.21M delivery order to Roche Diagnostics Corporation for chemistry and immunoassay testing services, effective October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract represents a child order under a larger vehicle and carries no set-aside designation, allowing Roche to compete openly in the federal marketplace. The work will be performed at Fort Sam Houston in San Antonio, Texas, a major military medical facility....
- This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of reagents and peripheral supplies. The contract was awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price, and has a potential value of $2,238,187.65. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures in vitro diagnostics, reagents, laboratory...